发明名称 Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives
摘要 Inflammation or damage associated with myocardial events is treated or prevented by administration of an angiogenesis-inducing, anti-inflammatory peptide such as Thymosin β4, an isoform of Thymosin β4 or oxidized Thymosin β4.
申请公布号 US9056087(B2) 申请公布日期 2015.06.16
申请号 US200210488084 申请日期 2002.08.29
申请人 REGENERX BIOPHARMACEUTICALS, INC. 发明人 Goldstein Allan L.;Finkelstein, Jr. Jack
分类号 A61K38/22;C07K16/26;A61K39/00 主分类号 A61K38/22
代理机构 Rothwell, Figg, Ernst & Manbeck, P.C. 代理人 Rothwell, Figg, Ernst & Manbeck, P.C.
主权项 1. A method of enhancing myocardial tissue cell differentiation in a subject in need thereof, wherein cardiac endothelial cells are transformed to mesenchymal cells, comprising administering to said subject a composition comprising an effective amount of thymosin beta 4 (Tβ4) and a pharmaceutically acceptable carrier, wherein said Tβ4 is administered in a dosage of about 0.1 to 50 micrograms and at a concentration of 0.001-10% by weight.
地址 Rockville MD US